Fundraising Fox
/Companies
Sign in

Cellular Logistics

Madison, US · Founded 2016 · Wisconsin corporation

Find your way into Cellular Logistics

Each arrow is one introduction. Sign up to fill in the first one.

7 people can intro you to Alex

Ask José Luis Curbelo to introduce you to Alex Vodenlich

You →José · together at University of Wisconsin-Madison →Alex

Sign up to find every way you can get introduced to Cellular Logistics

  • Your email: who you already know at Cellular Logistics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cellular Logistics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Cellular Logistics develops biological products focused on cardiac treatments, combining expertise in cell therapy and cGMP manufacturing to advance novel therapies for heart failure and interventional cardiology applications.

BiotechHealthtechMedical DevicesNew Materials

Founders & leadership

AVAlex Vodenlich
Alex VodenlichExecutiveAlex Vodenlich is an Executive Officer and Director at Cellular Logistics, which develops cell therapy products for cardiac treatments. He brings over 30 years of leadership experience in small business management and life sciences.
ES
Eric SchmuckNamed on SEC filing
AR
Amish RavalNamed on SEC filing

Board

PR
Paul ResnickBoard director

Reported raises · per SEC filings

Form D private placements

$1.1M disclosed across 8 rounds · 2016–2026

▶$50KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Amish RavalExecutive Officer, Director
  • Eric SchmuckExecutive Officer
  • Alex VodenlichExecutive Officer, Director
Offering amount
$100K
Amount sold
$50K
Minimum investment
$25K
Proceeds to insiders
$10K
First sale
Jun 2026
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50KraisedApr 2025 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alex VodenlichExecutive Officer, Director
  • Eric SchmuckExecutive Officer
  • Amish RavalExecutive Officer, Director
Offering amount
$350K
Amount sold
$50K
Minimum investment
$25K
Proceeds to insiders
$50K
First sale
Mar 2025
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50KraisedMar 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric SchmuckExecutive Officer
  • Alex VodenlichExecutive Officer, Director
  • Paul ResnickDirector
  • Amish RavalDirector
Offering amount
$350K
Amount sold
$50K
Minimum investment
$25K
Proceeds to insiders
$50K
First sale
Mar 2023
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.5KraisedMay 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Amish RavalDirector
  • Eric SchmuckExecutive Officer
  • Alex VodenlichExecutive Officer, Director
  • Paul ResnickDirector
Offering amount
$37.5K
Amount sold
$37.5K
Minimum investment
$37.5K
First sale
May 2021
Incorporated
Corporation, Wisconsin, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$75KraisedJun 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zach BowerExecutive Officer
  • Amish RavalExecutive Officer, Director, Promoter
  • Eric SchmuckExecutive Officer, Promoter
  • Alex VodenlichExecutive Officer, Director
  • Paul ResnickDirector
Offering amount
$500K
Amount sold
$75K
Minimum investment
$25K
Proceeds to insiders
$50K
First sale
May 2019
Incorporated
Corporation, Wisconsin, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$617.7KraisedNov 2018 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam BockPromoter
  • Alex VodenlichExecutive Officer
  • Eric SchmuckExecutive Officer, Promoter
  • Amish RavalExecutive Officer, Director, Promoter
  • Peiman HemattiExecutive Officer, Promoter
Offering amount
$617.7K
Amount sold
$617.7K
Minimum investment
$25K
Proceeds to insiders
$65K
First sale
Nov 2018
Incorporated
Corporation, Wisconsin, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5KraisedJun 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam BockExecutive Officer, Director, Promoter
  • Amish RavalExecutive Officer, Director, Promoter
  • Rakesh SoniExecutive Officer, Director
  • Eric SchmuckExecutive Officer, Promoter
  • Peiman HemattiExecutive Officer, Promoter
Offering amount
$5K
Amount sold
$5K
First sale
Jun 2017
Incorporated
Corporation, Wisconsin, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$185KraisedNov 2016 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Amish RavalExecutive Officer, Director, Promoter
  • Peiman HemattiExecutive Officer, Promoter
  • Eric SchmuckExecutive Officer, Promoter
  • Rakesh SoniExecutive Officer
  • Adam BockExecutive Officer, Director, Promoter
Offering amount
$500K
Amount sold
$185K
Proceeds to insiders
$65K
First sale
Nov 2016
Incorporated
Corporation, Wisconsin, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

CEL SCICEL-SCI Corporation is a biotech company developing immunotherapies, particularly Multikine, which is advancing through FDA regulatory processes. The company is focused on cancer treatment and has progressed to Phase 3 clinical trials.

Companies working in the same space as Cellular Logistics.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$337.1K
National Institutes of Health (NIH)National Institutes of HealthPhase I2021$320.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Cellular Logistics do?
Cellular Logistics develops biological products focused on cardiac treatments, combining expertise in cell therapy and cGMP manufacturing to advance novel therapies for heart failure and interventional cardiology applications.
How much funding has Cellular Logistics raised?
Cellular Logistics has disclosed $1.1M raised across 8 rounds.
Where is Cellular Logistics headquartered?
Cellular Logistics is headquartered in Madison, US.